Use of in-house studies of molecular epidemiology and full species identification for controlling spread of vancomycin-resistant Enterococcus faecalis isolates
- 1 September 1996
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 34 (9) , 2129-2132
- https://doi.org/10.1128/jcm.34.9.2129-2132.1996
Abstract
Infection with multidrug-resistant (MDR) organisms is a major clinical challenge, and few, if any, therapeutic options remain available. Increasingly, infection control measures have taken on greater importance in preventing the nosocomial transmission of MDR organisms. During December 1994 and January 1995, we identified a cluster of vancomycin-resistant Enterococcus faecalis isolates involving 16 patients situated in different areas of our university-affiliated teaching hospital. Initial review of laboratory requisition forms for the patients' locations revealed no common association, suggesting that the occurrence was not due to horizontal spread. However, using genomic DNA extraction, restriction enzyme analysis, and gel electrophoresis, we found that 12 patients were infected with isolates originating from a single clone, 2 other patients were infected with isolates from a different clone, and the remaining 2 patients were infected with unique strains. Because the typing data suggested nosocomial spread, chart review was undertaken to determine a possible common exposure source. With three exceptions, clonal isolates were linked to patient movement between surgical floors, intensive care units, and a rehabilitation unit. A detailed review of patient records revealing the association would not have been performed without realization of clonality. Thus, the data demonstrate the utility of genomic typing for epidemiological purposes. In turn, targeted infection control measures that halted the spread of the potentially lethal MDR pathogen were instituted.Keywords
This publication has 15 references indexed in Scilit:
- Enterococci Resistant to Multiple Antimicrobial Agents, Including Vancomycin: Establishment of Endemicity in a University Medical CenterAnnals of Internal Medicine, 1995
- Reducing the Spread of Antimicrobial-Resistant Microorganisms: Control of Vancomycin-Resistant EnterococciPediatric Clinics of North America, 1995
- Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faeciumJournal of Antimicrobial Chemotherapy, 1994
- Emergence of vancomycin-resistant enterococci in New York CityThe Lancet, 1993
- Medical technologists using molecular epidemiology as part of the infection control teamDiagnostic Microbiology and Infectious Disease, 1993
- Intrahospital spread of a single gentamicin-resistant, beta-lactamase-producing strain of Enterococcus faecalis in ArgentinaAntimicrobial Agents and Chemotherapy, 1992
- Evidence for clonal spread of a single strain of beta-lactamase-producing Enterococcus (Streptococcus) faecalis to six hospitals in five states.1991
- Rapid Dissemination of β-Lactamase–Producing, Aminoglycoside-ResistantEnterococcus faecalisamong Patients and Staff on an Infant–Toddler Surgical WardNew England Journal of Medicine, 1990
- High-level aminoglycoside-resistant enterococci. Colonization of nursing home and acute care hospital patientsArchives of internal medicine (1960), 1987
- High-Level Resistance to Gentamicin in Streptococcus faecalis: Risk Factors and Evidence for Exogenous Acquisition of InfectionThe Journal of Infectious Diseases, 1986